156 related articles for article (PubMed ID: 35500378)
21. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
[TBL] [Abstract][Full Text] [Related]
22. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
[TBL] [Abstract][Full Text] [Related]
23. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
[TBL] [Abstract][Full Text] [Related]
24. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
[TBL] [Abstract][Full Text] [Related]
25. Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation.
Murakami N; Ishikawa T; Kondo T; Imamura K; Tsukita K; Enami T; Funayama M; Shibukawa R; Matsumoto S; Izumi Y; Ohta E; Obata F; Kaji R; Inoue H
Stem Cell Res; 2017 Oct; 24():36-39. PubMed ID: 29034893
[TBL] [Abstract][Full Text] [Related]
26. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.
Marote A; Pomeshchik Y; Collin A; Goldwurm S; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Apr; 28():44-47. PubMed ID: 29414418
[TBL] [Abstract][Full Text] [Related]
27. Generation of an induced pluripotent stem cell line (ZZUi020-A) from a patient with Parkinson's disease harboring the intermediate-length GGC repeat expansions in the NOTCH2NLC gene.
Fan Y; Liu F; Fan LY; Mao CY; Liu H; Zhang C; Yuan YP; Yang J; Wang YL; Liu YT; Shi CH; Xu YM
Stem Cell Res; 2021 Apr; 52():102257. PubMed ID: 33626493
[TBL] [Abstract][Full Text] [Related]
28. Production of a human iPSC line from an early-onset Parkinson's disease patient with a novel CHCHD2 gene truncated mutation.
Jiang Z; Gu XJ; Su WM; Duan QQ; Lin JY; Cao B; Shang HF; Chen YP
Stem Cell Res; 2022 Oct; 64():102881. PubMed ID: 35944313
[TBL] [Abstract][Full Text] [Related]
29. IPSC-Derived Astrocytes Contribute to In Vitro Modeling of Parkinson's Disease Caused by the
Yarkova ES; Grigor'eva EV; Medvedev SP; Pavlova SV; Zakian SM; Malakhova AA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203497
[TBL] [Abstract][Full Text] [Related]
30. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.
Jang J; Yoo JE; Lee JA; Lee DR; Kim JY; Huh YJ; Kim DS; Park CY; Hwang DY; Kim HS; Kang HC; Kim DW
Exp Mol Med; 2012 Mar; 44(3):202-13. PubMed ID: 22179105
[TBL] [Abstract][Full Text] [Related]
31. Generation of integration-free human iPSC line LCPHi001-A from a Parkinson's disease patient carrying the RecNciI mutation in GBA gene.
Lu X; Song N; Wang W; Liu Y; Song H; Xu L; Wang Y; Wei C; Chen J; Yang X; Han F
Stem Cell Res; 2021 Oct; 56():102514. PubMed ID: 34464855
[TBL] [Abstract][Full Text] [Related]
32. Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient.
Ma J; Guo R; Song Y; Zhang J; Feng B; Amponsah AE; Kong D; He J; Zhang W; Liu A; Wei L; Shen S; O'Brien T; Cui H
Stem Cell Res; 2019 Apr; 36():101417. PubMed ID: 30875588
[TBL] [Abstract][Full Text] [Related]
33. Generation of an induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a pathogenic LRP10/c.688C > T(p.Arg230Trp) mutation.
Wang Y; Wei C; Liu Y; Lu X; Wang W; Song N; Zhang W; Xu J; Zhang W; Han F
Stem Cell Res; 2024 Jun; 77():103359. PubMed ID: 38460235
[TBL] [Abstract][Full Text] [Related]
34. Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson's disease with PARK2 mutation.
Ishikawa KI; Okuzumi A; Yoshino H; Hattori N; Akamatsu W
Stem Cell Res; 2024 Apr; 76():103323. PubMed ID: 38309147
[TBL] [Abstract][Full Text] [Related]
35. Generation of an induced pluripotent stem cell line (ZJUi007-A) from a 11-year-old patient of Fabry disease.
Zhu Y; Zhang L; Wang G; Zhao J; Hou X; Wu H; Xu Y; Mao J; Liu Z; Zhang J
Stem Cell Res; 2021 Aug; 55():102475. PubMed ID: 34365103
[TBL] [Abstract][Full Text] [Related]
36. Derivation of an induced pluripotent stem cell line (MUSIi004-A) from dermal fibroblasts of a 48-year-old spinocerebellar ataxia type 3 patient.
Ritthaphai A; Wattanapanitch M; Pithukpakorn M; Heepchantree W; Soi-Ampornkul R; Mahaisavariya P; Triwongwaranat D; Pattanapanyasat K; Vatanashevanopakorn C
Stem Cell Res; 2018 Jul; 30():113-116. PubMed ID: 29852467
[TBL] [Abstract][Full Text] [Related]
37. Generation and characterization of iPS cell line (SYSUSHi002-A) from PBMCs of an AML patient with TP53 mutation.
Yuan L; Wang Y; Xie R; Lin D; Wang X
Stem Cell Res; 2023 Dec; 73():103230. PubMed ID: 37890328
[TBL] [Abstract][Full Text] [Related]
38. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Castresana M; Aguillón D; Villegas A; Mastronardi CA; Espinosa LG; Arcos-Burgos M; Del Pozo Á; Herrán E; Gainza E; Isaza-Ruget M; Lopera F; Bachiller D
Stem Cell Res; 2019 May; 37():101440. PubMed ID: 31026686
[TBL] [Abstract][Full Text] [Related]
39. Generation of three human induced pluripotent stem cell (hiPSC) lines derived from one Gaucher disease patient with Parkinson's disease and two unrelated Parkinson's disease patients with GBA mutations.
Tofoli FA; Chien HF; Barbosa ER; Pereira LV
Stem Cell Res; 2019 Aug; 39():101519. PubMed ID: 31401455
[TBL] [Abstract][Full Text] [Related]
40. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]